Skip to main content
Clinical Trials/NCT02741492
NCT02741492
Completed
Not Applicable

Continuous Transversus Abdominus Plane Block for Open Inguinal Hernia Repair

Benaroya Research Institute1 site in 1 country90 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post-Operative Pain
Sponsor
Benaroya Research Institute
Enrollment
90
Locations
1
Primary Endpoint
Opioid Consumption (Intravenous Morphine Equivalents)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study is designed to evaluate pain control of continuous transversus abdominis plane (TAP) blocks placed for open inguinal hernia repair. The investigators hypothesize that there will be improved pain control when compared with sham blocks.

Detailed Description

This study is a randomized, controlled trial designed to determine whether continuous transversus abdominis plane (TAP) block versus sham block has a substantial impact on pain following open inguinal hernia repair. Our primary outcome is to determine whether there will be a difference in opioid consumption within the first two days following surgery. Secondary outcomes will include: pain scores and activity assessment score.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
June 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Neil Hanson

Staff Anesthesiologist

Benaroya Research Institute

Eligibility Criteria

Inclusion Criteria

  • Unilateral open inguinal hernia repair
  • ASA physical status I-III
  • \>18 years old
  • Consent to participate in the study

Exclusion Criteria

  • Refusal to participate in the study
  • \<18 years old
  • Chronic opioid use
  • Localized infection
  • Pregnancy or lactating
  • Pre-existing coagulopathy or active anticoagulant use
  • Allergy to ultrasound gel or local anesthetics

Outcomes

Primary Outcomes

Opioid Consumption (Intravenous Morphine Equivalents)

Time Frame: 48 Hours

Total Opioid Consumption

Secondary Outcomes

  • Activity Assessment Score(30 Days)
  • Pain (Numeric Rating)(30 Days)

Study Sites (1)

Loading locations...

Similar Trials